Table 3.
Factors associated with treatment adherence according to adherence level among patients with mental disorders or cardiovascular diseases or both conditions who were recruited for the French Carenity platform study (N=820).
| Factors | Total | Poorly adherent, n (%) | Partially adherent, n (%) | Mostly adherent, n (%) | Perfectly adherent, n (%) | P value | |||
| Gender | ≤.001 | ||||||||
|
|
Female | 542 | 166 (30.6) | 172 (31.7) | 100 (18.5) | 104 (19.2) |
|
|
|
|
|
Male | 278 | 50 (18) | 76 (27.3) | 82 (29.5) | 70 (25.2) |
|
|
|
| Age group (years) | ≤.001 | ||||||||
|
|
≥65 | 189 | 27 (14.3) | 50 (26.5) | 46 (24.3) | 66 (34.9) |
|
|
|
|
|
<65 | 631 | 189 (30) | 198 (31.4) | 136 (21.6) | 108 (17.1) |
|
|
|
| Disease type | ≤.001 | ||||||||
|
|
Cardiovascular diseases only | 403 | 63 (15.6) | 112 (27.8) | 109 (27) | 119 (29.5) |
|
|
|
|
|
Mental disorders only | 292 | 115 (39.4) | 96 (32.9) | 49 (16.8) | 32 (11) |
|
|
|
| Complexity of treatment regimen | ≤.001a | ||||||||
|
|
Simple | 269 | 58 (21.6) | 75 (27.9) | 61 (22.7) | 75 (27.9) |
|
|
|
|
|
Intermediate | 204 | 52 (25.5) | 61 (29.9) | 54 (26.5) | 37 (18.1) |
|
|
|
|
|
Complex | 347 | 106 (30.5) | 112 (32.3) | 67 (19.3) | 62 (17.9) |
|
|
|
| Fear of treatment risks | ≤.001 | ||||||||
|
|
No | 125 | 17 (13.6) | 23 (18.4) | 39 (31.2) | 46 (36.8) |
|
|
|
|
|
Yes | 695 | 199 (28.6) | 225 (32.4) | 143 (20.6) | 128 (18.4) |
|
|
|
| Worry about treatment constraints | ≤.001 | ||||||||
|
|
No | 262 | 56 (21.4) | 72 (27.5) | 80 (30.5) | 84 (32.1) |
|
|
|
|
|
Yes | 528 | 160 (30.3) | 176 (33.3) | 102 (19.3) | 90 (17.1) |
|
|
|
| Received information on treatment benefits and impact on health | ≤.001 | ||||||||
|
|
Yes | 599 | 126 (21) | 188 (31.4) | 144 (24) | 141 (23.6) |
|
|
|
|
|
Yes partially | 142 | 64 (45.1) | 42 (29.6) | 21 (14.8) | 15 (10.5) |
|
|
|
|
|
No | 79 | 26 (32.9 | 18 (22.8) | 17 (21.5) | 18 (22.8) |
|
|
|
| Received information on adverse effects | ≤.01 | ||||||||
|
|
Yes | 660 | 162 (24.5) | 208 (31.5) | 148 (22.4) | 142 (21.5) |
|
|
|
|
|
No | 160 | 54 (33.7) | 40 (25) | 34 (21.3) | 32 (20) |
|
|
|
aThe P value only refers to the comparison of the simple and complex treatment regimens.